Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysis

Tamirat Bekele Beressa, Tamiru Sahilu, Serawit Deyno
doi: https://doi.org/10.1101/2020.09.03.20187393

Article usage

Article usage: September 2020 to August 2025

AbstractFullPdf
Sep 20204370179
Oct 2020101070
Nov 2020107045
Dec 202061033
Jan 202152013
Feb 202176015
Mar 202192724
Apr 20219236
May 202158010
Jun 202159112
Jul 202139526
Aug 202139617
Sep 202134012
Oct 202140023
Nov 202138417
Dec 20213036
Jan 20223687
Feb 20222241
Mar 20223177
Apr 20223026
May 202227015
Jun 20222919
Jul 20222813
Aug 20222413
Sep 20223518
Oct 20222905
Nov 20222115
Dec 20222715
Jan 20233024
Feb 20231938
Mar 20232218
Apr 202327134
May 202317110
Jun 20231749
Jul 20231203
Aug 202323226
Sep 202318811
Oct 202320106
Nov 202329137
Dec 20231745
Jan 20241033
Feb 202418317
Mar 20242064
Apr 20241379
May 202417712
Jun 20241634
Jul 20241854
Aug 20242577
Sep 20243585
Oct 20241673
Nov 2024211117
Dec 202416225
Jan 202517144
Feb 202512205
Mar 2025312911
Apr 20251757
May 2025141110
Jun 2025412011
Jul 202517128
Aug 2025001
Back to top
Posted September 04, 2020.
Download PDF
Data/Code
Email
Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysis
Tamirat Bekele Beressa, Tamiru Sahilu, Serawit Deyno
medRxiv 2020.09.03.20187393; doi: https://doi.org/10.1101/2020.09.03.20187393
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area